HUM

Humana operates primarily in the health insurance sector, offering medical and specialty insurance products, with a significant focus on Medicare Advantage plans. The company also provides Medicaid and commercial insurance options. Humana differentiates itself through its integrated care delivery model, CenterWell, which includes primary care, pharmacy, and home health services. While a market leader, Humana faces intense competition from other large insurers and is subject to regulatory changes in the healthcare industry.

Humana's current price reflects a discount compared to its 52-week high and the average analyst target price, suggesting potential undervaluation. The P/E ratio is slightly above the industry average, while the forward P/E is lower, indicating expected earnings growth. The price-to-sales and price-to-book ratios are relatively low, further supporting the possibility of undervaluation. However, the absence of a PEG ratio makes growth assessment difficult.